Springhill Fund

Springhill Management is a private fund management company that specializes in offering services for biotechnology and social impact funds. The firm provides strategic investment and advisory support to ventures focused on advancing life sciences and generating positive societal outcomes, integrating both financial and social returns through its distinct investment approach.

The organization operates under the chairmanship of Dato Dr Kim Tan, a prominent figure in impact investing. His extensive background includes partnerships in various impact funds, such as Inqo Investments and Novastar Ventures, alongside his role as co-founder of the Transformational Business Network. This experience underpins Springhill’s commitment to funding enterprises that demonstrate both innovation and a clear social purpose.

Springhill Management serves a diverse clientele that includes established funds and emerging companies in sectors ranging from biotech to broader social enterprises. The firm’s long-term vision centers on cultivating a portfolio of investments that not only yield robust financial performance but also contribute meaningfully to global challenges, particularly within health and social development.